Asia-Pacific Prosthetic Heart Valve Market By Product (Tissue Heart Valve, Mechanical Heart Valve, Transcatheter Heart Valve) , : Opportunity Analysis and Industry Forecast, 2024-2033
Asia-Pacific Prosthetic Heart Valve Market
The Asia-Pacific prosthetic heart valve market was valued at $2.0 billion in 2023 and is projected to reach $6.2 billion by 2033, growing at a CAGR of 11.9% from 2024 to 2033.
A prosthetic heart valve is an artificial implant that replaces the damaged native valve of the human heart for its efficient functioning. It is either mechanical, formed from plastic or metal, or bioprosthetic, which is created using animal or human tissues. Similar to the natural heart valves, a prosthetic heart valve opens & closes during every heartbeat and enables sufficient flow of blood into the body. A major advantage of the prosthetic heart valve is its durability as it functions ideally for 20-30 years after implantation. This reduces the possibility of blood clotting around the valve surface and eliminates the requirement for lifelong blood thinning therapies.
Asia-Pacific harbors the highest geriatric population across the globe. This fuels the demand for prosthetic heart valves and propels the growth of the market. In addition, upsurge in expenditure on healthcare by consumers acts as a key driver of the Asia-Pacific prosthetic heart valve market. Furthermore, surge in the implementation of supportive government strategies across different nations to expand their health service industry is expected to augment the market development. To enhance the efficacy and biomimicry of prosthetic heart valves, the use of latest techniques of 3D printing is trending in the market. Manufacturers are utilizing biomaterial inks and ingenious techniques such as bioplotting & melt electrowriting to print living cells.
However, high costs of the valves and implantation surgeries deters several patients with budget sensitivities from undergoing the procedure. This limits the demand for prosthetic heart valves and hampers the market development. Moreover, staffing problems in the region due to the lack of skilled healthcare providers and surgeons have an overall restraining impact on the Asia-Pacific prosthetic heart valve market. On the contrary, rise in prevalence of cardiovascular diseases (CVD) in the region is poised to present lucrative opportunities for the market growth. According to the Asia-Pacific Cardiovascular Disease Alliance, a multisectoral coalition, CVD is the leading cause of death in Asia-Pacific, accounting for approximately 35% of the overall mortality. Furthermore, the region alone contributes to around 58% of the global CVD deaths every year. These figures are poised to rise in the future, thereby fueling the demand for efficient cardiovascular healthcare and opening new avenues for the Asia-Pacific prosthetic heart valve market.
Segment Review
The Asia-Pacific prosthetic heart valve market is segmented into product and region. On the basis of product, the market is divided into tissue heart valve, mechanical heart valve, and transcatheter heart valve. Country wise, it is analyzed across Japan, China, India, Australia, South Korea, and Rest of Asia-Pacific.
Key Findings
On the basis of product, the transcatheter heart valve segment held a high share of the market in 2023.
Competition Analysis
The leading players operating in the Asia-Pacific prosthetic heart valve market include Edwards Lifesciences Corporation, TTK, SMT, Relisys Medical Devices Limited, Medtronic, Heart Care India Co., Boston Scientific Corporation, Meril Life Sciences Pvt. Ltd., P+F Products + Features GmbH, and Peijia Medical Limited. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.
Key Market Segments
By Product
Tissue Heart Valve
Stented Tissue Heart Valve
Stentless Tissue Heart Valve
Mechanical Heart Valve
Transcatheter Heart Valve
By Country
Japan
China
India
Australia
South Korea
Rest Of Asia-Pacific
Key Market Players
Edwards Lifesciences Corporation
TTK
SMT
Relisys Medical Devices Limited
Medtronic
Heart Care India Co
Boston Scientific Corporation
Meril Life Sciences Pvt. Ltd.
P+F Products + Features GmbH
Peijia Medical Limited
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- CHAPTER 4: ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, BY PRODUCT
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Product
- 4.2. Tissue Heart Valve
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Share Analysis, By Country
- 4.2.3. Stented Tissue Heart Valve
- 4.2.4. Stentless Tissue Heart Valve
- 4.3. Mechanical Heart Valve
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Share Analysis, By Country
- 4.4. Transcatheter Heart Valve
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Share Analysis, By Country
- CHAPTER 5: ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, BY COUNTRY
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Country
- 5.2. Asia-Pacific
- 5.2.2. Key Market Trends and Opportunities
- 5.2.2. Market Size and Forecast, By Product
- 5.2.3. Market Size and Forecast, By Country
- 5.2.4.Japan
- 5.2.4.1. Market Size and Forecast, By Product
- 5.2.5.China
- 5.2.5.1. Market Size and Forecast, By Product
- 5.2.6.India
- 5.2.6.1. Market Size and Forecast, By Product
- 5.2.7.Australia
- 5.2.7.1. Market Size and Forecast, By Product
- 5.2.8.South Korea
- 5.2.8.1. Market Size and Forecast, By Product
- 5.2.9.Rest of Asia Pacific
- 5.2.9.1. Market Size and Forecast, By Product
- CHAPTER 6: COMPETITIVE LANDSCAPE
- 6.1. Introduction
- 6.2. Top Winning Strategies
- 6.3. Product Mapping Of Top 10 Player
- 6.4. Competitive Dashboard
- 6.5. Competitive Heatmap
- 6.6. Top Player Positioning,2023
- CHAPTER 7: COMPANY PROFILES
- 7.1. Edwards Lifesciences Corporation
- 7.1.1. Company Overview
- 7.1.2. Key Executives
- 7.1.3. Company Snapshot
- 7.1.4. Operating Business Segments
- 7.1.5. Product Portfolio
- 7.1.6. Business Performance
- 7.1.7. Key Strategic Moves and Developments
- 7.2. TTK
- 7.2.1. Company Overview
- 7.2.2. Key Executives
- 7.2.3. Company Snapshot
- 7.2.4. Operating Business Segments
- 7.2.5. Product Portfolio
- 7.2.6. Business Performance
- 7.2.7. Key Strategic Moves and Developments
- 7.3. SMT
- 7.3.1. Company Overview
- 7.3.2. Key Executives
- 7.3.3. Company Snapshot
- 7.3.4. Operating Business Segments
- 7.3.5. Product Portfolio
- 7.3.6. Business Performance
- 7.3.7. Key Strategic Moves and Developments
- 7.4. Relisys Medical Devices Limited
- 7.4.1. Company Overview
- 7.4.2. Key Executives
- 7.4.3. Company Snapshot
- 7.4.4. Operating Business Segments
- 7.4.5. Product Portfolio
- 7.4.6. Business Performance
- 7.4.7. Key Strategic Moves and Developments
- 7.5. Medtronic
- 7.5.1. Company Overview
- 7.5.2. Key Executives
- 7.5.3. Company Snapshot
- 7.5.4. Operating Business Segments
- 7.5.5. Product Portfolio
- 7.5.6. Business Performance
- 7.5.7. Key Strategic Moves and Developments
- 7.6. Heart Care India Co
- 7.6.1. Company Overview
- 7.6.2. Key Executives
- 7.6.3. Company Snapshot
- 7.6.4. Operating Business Segments
- 7.6.5. Product Portfolio
- 7.6.6. Business Performance
- 7.6.7. Key Strategic Moves and Developments
- 7.7. Boston Scientific Corporation
- 7.7.1. Company Overview
- 7.7.2. Key Executives
- 7.7.3. Company Snapshot
- 7.7.4. Operating Business Segments
- 7.7.5. Product Portfolio
- 7.7.6. Business Performance
- 7.7.7. Key Strategic Moves and Developments
- 7.8. Meril Life Sciences Pvt. Ltd.
- 7.8.1. Company Overview
- 7.8.2. Key Executives
- 7.8.3. Company Snapshot
- 7.8.4. Operating Business Segments
- 7.8.5. Product Portfolio
- 7.8.6. Business Performance
- 7.8.7. Key Strategic Moves and Developments
- 7.9. P+F Products + Features GmbH
- 7.9.1. Company Overview
- 7.9.2. Key Executives
- 7.9.3. Company Snapshot
- 7.9.4. Operating Business Segments
- 7.9.5. Product Portfolio
- 7.9.6. Business Performance
- 7.9.7. Key Strategic Moves and Developments
- 7.10. Peijia Medical Limited
- 7.10.1. Company Overview
- 7.10.2. Key Executives
- 7.10.3. Company Snapshot
- 7.10.4. Operating Business Segments
- 7.10.5. Product Portfolio
- 7.10.6. Business Performance
- 7.10.7. Key Strategic Moves and Developments
- LIST OF TABLES
- TABLE 1. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 2. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET FOR TISSUE HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 3. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET FOR MECHANICAL HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 4. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET FOR TRANSCATHETER HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 5. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 6. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 7. JAPAN PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 8. CHINA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 9. INDIA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 10. AUSTRALIA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 11. SOUTH KOREA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 12. REST OF ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 13. EDWARDS LIFESCIENCES CORPORATION: KEY EXECUTIVES
- TABLE 14. EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
- TABLE 15. EDWARDS LIFESCIENCES CORPORATION: OPERATING SEGMENTS
- TABLE 16. EDWARDS LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO
- TABLE 17. EDWARDS LIFESCIENCES CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 18. TTK: KEY EXECUTIVES
- TABLE 19. TTK: COMPANY SNAPSHOT
- TABLE 20. TTK: OPERATING SEGMENTS
- TABLE 21. TTK: PRODUCT PORTFOLIO
- TABLE 22. TTK: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 23. SMT: KEY EXECUTIVES
- TABLE 24. SMT: COMPANY SNAPSHOT
- TABLE 25. SMT: OPERATING SEGMENTS
- TABLE 26. SMT: PRODUCT PORTFOLIO
- TABLE 27. SMT: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 28. RELISYS MEDICAL DEVICES LIMITED: KEY EXECUTIVES
- TABLE 29. RELISYS MEDICAL DEVICES LIMITED: COMPANY SNAPSHOT
- TABLE 30. RELISYS MEDICAL DEVICES LIMITED: OPERATING SEGMENTS
- TABLE 31. RELISYS MEDICAL DEVICES LIMITED: PRODUCT PORTFOLIO
- TABLE 32. RELISYS MEDICAL DEVICES LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 33. MEDTRONIC: KEY EXECUTIVES
- TABLE 34. MEDTRONIC: COMPANY SNAPSHOT
- TABLE 35. MEDTRONIC: OPERATING SEGMENTS
- TABLE 36. MEDTRONIC: PRODUCT PORTFOLIO
- TABLE 37. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 38. HEART CARE INDIA CO: KEY EXECUTIVES
- TABLE 39. HEART CARE INDIA CO: COMPANY SNAPSHOT
- TABLE 40. HEART CARE INDIA CO: OPERATING SEGMENTS
- TABLE 41. HEART CARE INDIA CO: PRODUCT PORTFOLIO
- TABLE 42. HEART CARE INDIA CO: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 43. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
- TABLE 44. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
- TABLE 45. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
- TABLE 46. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
- TABLE 47. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 48. MERIL LIFE SCIENCES PVT. LTD.: KEY EXECUTIVES
- TABLE 49. MERIL LIFE SCIENCES PVT. LTD.: COMPANY SNAPSHOT
- TABLE 50. MERIL LIFE SCIENCES PVT. LTD.: OPERATING SEGMENTS
- TABLE 51. MERIL LIFE SCIENCES PVT. LTD.: PRODUCT PORTFOLIO
- TABLE 52. MERIL LIFE SCIENCES PVT. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 53. P+F PRODUCTS + FEATURES GMBH: KEY EXECUTIVES
- TABLE 54. P+F PRODUCTS + FEATURES GMBH: COMPANY SNAPSHOT
- TABLE 55. P+F PRODUCTS + FEATURES GMBH: OPERATING SEGMENTS
- TABLE 56. P+F PRODUCTS + FEATURES GMBH: PRODUCT PORTFOLIO
- TABLE 57. P+F PRODUCTS + FEATURES GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 58. PEIJIA MEDICAL LIMITED: KEY EXECUTIVES
- TABLE 59. PEIJIA MEDICAL LIMITED: COMPANY SNAPSHOT
- TABLE 60. PEIJIA MEDICAL LIMITED: OPERATING SEGMENTS
- TABLE 61. PEIJIA MEDICAL LIMITED: PRODUCT PORTFOLIO
- TABLE 62. PEIJIA MEDICAL LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
- LIST OF FIGURES
- FIGURE 1. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET,2024 - 2033
- FIGURE 2. SEGMENTATION OF ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET,2024 - 2033
- FIGURE 3. TOP INVESTMENT POCKET IN ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET,2024 - 2033
- FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 7. LOW THREAT OF SUBSTITUTION
- FIGURE 8. HIGH COMPETITIVE RIVALRY
- FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET
- FIGURE 10. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET , BY PRODUCT,2024 - 2033 ($BILLION)
- FIGURE 11. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET FOR TISSUE HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 12. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET FOR MECHANICAL HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 13. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET FOR TRANSCATHETER HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 14. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
- FIGURE 15. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
- FIGURE 16. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
- FIGURE 17. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 18. COMPETITIVE DASHBOARD
- FIGURE 19. COMPETITIVE HEATMAP: ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET
- FIGURE 20. TOP PLAYER POSITIONING,2023
- FIGURE 21. EDWARDS LIFESCIENCES CORPORATION: NET SALES, 2021-2023 ($BILLION)
- FIGURE 22. EDWARDS LIFESCIENCES CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 23. EDWARDS LIFESCIENCES CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 24. TTK: NET SALES, 2021-2023 ($BILLION)
- FIGURE 25. TTK: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 26. TTK: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 27. SMT: NET SALES, 2021-2023 ($BILLION)
- FIGURE 28. SMT: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 29. SMT: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 30. RELISYS MEDICAL DEVICES LIMITED: NET SALES, 2021-2023 ($BILLION)
- FIGURE 31. RELISYS MEDICAL DEVICES LIMITED: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 32. RELISYS MEDICAL DEVICES LIMITED: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 33. MEDTRONIC: NET SALES, 2021-2023 ($BILLION)
- FIGURE 34. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 35. MEDTRONIC: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 36. HEART CARE INDIA CO: NET SALES, 2021-2023 ($BILLION)
- FIGURE 37. HEART CARE INDIA CO: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 38. HEART CARE INDIA CO: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 39. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2021-2023 ($BILLION)
- FIGURE 40. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 41. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 42. MERIL LIFE SCIENCES PVT. LTD.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 43. MERIL LIFE SCIENCES PVT. LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 44. MERIL LIFE SCIENCES PVT. LTD.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 45. P+F PRODUCTS + FEATURES GMBH: NET SALES, 2021-2023 ($BILLION)
- FIGURE 46. P+F PRODUCTS + FEATURES GMBH: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 47. P+F PRODUCTS + FEATURES GMBH: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 48. PEIJIA MEDICAL LIMITED: NET SALES, 2021-2023 ($BILLION)
- FIGURE 49. PEIJIA MEDICAL LIMITED: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 50. PEIJIA MEDICAL LIMITED: REVENUE SHARE, BY REGION, 2023 (%)
- LIST OF TABLES
- TABLE 1. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 2. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET FOR TISSUE HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 3. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET FOR MECHANICAL HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 4. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET FOR TRANSCATHETER HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 5. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 6. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 7. JAPAN PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 8. CHINA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 9. INDIA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 10. AUSTRALIA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 11. SOUTH KOREA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 12. REST OF ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 13. EDWARDS LIFESCIENCES CORPORATION: KEY EXECUTIVES
- TABLE 14. EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
- TABLE 15. EDWARDS LIFESCIENCES CORPORATION: OPERATING SEGMENTS
- TABLE 16. EDWARDS LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO
- TABLE 17. EDWARDS LIFESCIENCES CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 18. TTK: KEY EXECUTIVES
- TABLE 19. TTK: COMPANY SNAPSHOT
- TABLE 20. TTK: OPERATING SEGMENTS
- TABLE 21. TTK: PRODUCT PORTFOLIO
- TABLE 22. TTK: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 23. SMT: KEY EXECUTIVES
- TABLE 24. SMT: COMPANY SNAPSHOT
- TABLE 25. SMT: OPERATING SEGMENTS
- TABLE 26. SMT: PRODUCT PORTFOLIO
- TABLE 27. SMT: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 28. RELISYS MEDICAL DEVICES LIMITED: KEY EXECUTIVES
- TABLE 29. RELISYS MEDICAL DEVICES LIMITED: COMPANY SNAPSHOT
- TABLE 30. RELISYS MEDICAL DEVICES LIMITED: OPERATING SEGMENTS
- TABLE 31. RELISYS MEDICAL DEVICES LIMITED: PRODUCT PORTFOLIO
- TABLE 32. RELISYS MEDICAL DEVICES LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 33. MEDTRONIC: KEY EXECUTIVES
- TABLE 34. MEDTRONIC: COMPANY SNAPSHOT
- TABLE 35. MEDTRONIC: OPERATING SEGMENTS
- TABLE 36. MEDTRONIC: PRODUCT PORTFOLIO
- TABLE 37. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 38. HEART CARE INDIA CO: KEY EXECUTIVES
- TABLE 39. HEART CARE INDIA CO: COMPANY SNAPSHOT
- TABLE 40. HEART CARE INDIA CO: OPERATING SEGMENTS
- TABLE 41. HEART CARE INDIA CO: PRODUCT PORTFOLIO
- TABLE 42. HEART CARE INDIA CO: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 43. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
- TABLE 44. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
- TABLE 45. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
- TABLE 46. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
- TABLE 47. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 48. MERIL LIFE SCIENCES PVT. LTD.: KEY EXECUTIVES
- TABLE 49. MERIL LIFE SCIENCES PVT. LTD.: COMPANY SNAPSHOT
- TABLE 50. MERIL LIFE SCIENCES PVT. LTD.: OPERATING SEGMENTS
- TABLE 51. MERIL LIFE SCIENCES PVT. LTD.: PRODUCT PORTFOLIO
- TABLE 52. MERIL LIFE SCIENCES PVT. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 53. P+F PRODUCTS + FEATURES GMBH: KEY EXECUTIVES
- TABLE 54. P+F PRODUCTS + FEATURES GMBH: COMPANY SNAPSHOT
- TABLE 55. P+F PRODUCTS + FEATURES GMBH: OPERATING SEGMENTS
- TABLE 56. P+F PRODUCTS + FEATURES GMBH: PRODUCT PORTFOLIO
- TABLE 57. P+F PRODUCTS + FEATURES GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 58. PEIJIA MEDICAL LIMITED: KEY EXECUTIVES
- TABLE 59. PEIJIA MEDICAL LIMITED: COMPANY SNAPSHOT
- TABLE 60. PEIJIA MEDICAL LIMITED: OPERATING SEGMENTS
- TABLE 61. PEIJIA MEDICAL LIMITED: PRODUCT PORTFOLIO
- TABLE 62. PEIJIA MEDICAL LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
- LIST OF FIGURES
- FIGURE 1. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET,2024 - 2033
- FIGURE 2. SEGMENTATION OF ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET,2024 - 2033
- FIGURE 3. TOP INVESTMENT POCKET IN ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET,2024 - 2033
- FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 7. LOW THREAT OF SUBSTITUTION
- FIGURE 8. HIGH COMPETITIVE RIVALRY
- FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET
- FIGURE 10. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET , BY PRODUCT,2024 - 2033 ($BILLION)
- FIGURE 11. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET FOR TISSUE HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 12. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET FOR MECHANICAL HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 13. ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET FOR TRANSCATHETER HEART VALVE, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 14. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
- FIGURE 15. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
- FIGURE 16. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
- FIGURE 17. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 18. COMPETITIVE DASHBOARD
- FIGURE 19. COMPETITIVE HEATMAP: ASIA-PACIFIC PROSTHETIC HEART VALVE MARKET
- FIGURE 20. TOP PLAYER POSITIONING,2023
- FIGURE 21. EDWARDS LIFESCIENCES CORPORATION: NET SALES, 2021-2023 ($BILLION)
- FIGURE 22. EDWARDS LIFESCIENCES CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 23. EDWARDS LIFESCIENCES CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 24. TTK: NET SALES, 2021-2023 ($BILLION)
- FIGURE 25. TTK: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 26. TTK: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 27. SMT: NET SALES, 2021-2023 ($BILLION)
- FIGURE 28. SMT: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 29. SMT: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 30. RELISYS MEDICAL DEVICES LIMITED: NET SALES, 2021-2023 ($BILLION)
- FIGURE 31. RELISYS MEDICAL DEVICES LIMITED: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 32. RELISYS MEDICAL DEVICES LIMITED: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 33. MEDTRONIC: NET SALES, 2021-2023 ($BILLION)
- FIGURE 34. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 35. MEDTRONIC: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 36. HEART CARE INDIA CO: NET SALES, 2021-2023 ($BILLION)
- FIGURE 37. HEART CARE INDIA CO: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 38. HEART CARE INDIA CO: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 39. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2021-2023 ($BILLION)
- FIGURE 40. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 41. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 42. MERIL LIFE SCIENCES PVT. LTD.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 43. MERIL LIFE SCIENCES PVT. LTD.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 44. MERIL LIFE SCIENCES PVT. LTD.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 45. P+F PRODUCTS + FEATURES GMBH: NET SALES, 2021-2023 ($BILLION)
- FIGURE 46. P+F PRODUCTS + FEATURES GMBH: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 47. P+F PRODUCTS + FEATURES GMBH: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 48. PEIJIA MEDICAL LIMITED: NET SALES, 2021-2023 ($BILLION)
- FIGURE 49. PEIJIA MEDICAL LIMITED: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 50. PEIJIA MEDICAL LIMITED: REVENUE SHARE, BY REGION, 2023 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook